Kavita Vinod Paul: Transforming Lives Through Comprehensive Care and Community Leadership
Kavita Vinod Paul, National Sales Head at Novo Nordisk, shared a post on LinkedIn:
“I had the opportunity to meet Dr. Maganti BSV Prasad and team, whose unwavering commitment has transformed the lives of thousands of individuals living with hemophilia, thalassemia, sickle cell disease, von Willebrand disease, and other inherited blood disorders.
As the driving force behind the Hemophilia Society, Vijayawada Chapter – Eluru, Dr. Prasad has built far more than a patient support organization – he has created a legacy of compassionate care, early diagnosis, quality diagnostics, patient education, genetic counselling, physiotherapy, psychosocial support, and community empowerment that has touched three generations of patients and families.
What inspired me even more was the Society’s commitment to nurturing future leaders. Under Dr. Prasad’s guidance, the organization has mentored and inspired:
- 1 MD Radiologist
- 4 MBBS students
- 3 IIT graduates
- 3 PhD scholars
- 2 Chartered Accountants
- 3 NIT graduates
- 2 IIIT graduates
- 100 and more IT professionals
- 30 and more professionals serving in Government Services
This extraordinary contribution demonstrates that patient organizations can create an impact far beyond healthcare – empowering individuals, building careers, and inspiring generations of professionals committed to giving back to society.
The Hemophilia Society, Vijayawada Chapter, in collaboration with the Indian Red Cross Society, Eluru District Branch, is a remarkable example of how vision, partnerships, and selfless leadership can improve access to comprehensive care while creating lasting social impact.
My sincere gratitude to Dr. Maganti BSV Prasad and the entire team for their warm hospitality and for reminding us that true leadership is measured not only by the lives we heal but also by the lives we inspire.
Thank you Singa Reddy for the opportunity!”
Stay updated with Hemostasis Today.
-
Nov 8, 2026, 19:31Anna Kajaste-Rudnitski: Presenting AAV-Induced p53 Signalling in Human CNS Cells at ESGCT 26
-
Nov 8, 2026, 19:29David McIntosh: Cybersecurity Matters, but Blood Availability Remains the Bigger Challenge
-
Nov 8, 2026, 19:26Wenxue Ma: An Integrative Framework for Macrophage-Mediated Therapeutic Resistance in Cancer
-
Nov 8, 2026, 19:25Yildiz Yigit: Presenting a Polycythemia Vera Case at the MPN Subcommittee Session
-
Nov 8, 2026, 18:56Denis Oduor: Strengthening the Regulation and Delivery of Blood Transfusion and Transplantation Services
-
Nov 8, 2026, 18:28Raghavendra Rao: A Narrative Review on Chronic Venous Disease during Pregnancy
-
Nov 8, 2026, 17:57Dhiren Patel: PLD1-Derived Phospholipids Regulate NAD Kinase and ROS Production in Neutrophils
-
Nov 8, 2026, 17:48Andra T.: What Causes Antiphospholipid Syndrome? – Four Steps, not One Cause
-
Nov 8, 2026, 17:38Nasrin Samadi: Can a Normal Clotting Test Be Misleading?